Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases

Ophthalmology

Volumn 119, Issue 8, 2012, Pages 1569-1574

  Udoetuk, Joshua D ^a,c   Dai, Yang ^a   Ying, Gui Shuang ^a,b   Daniel, Ebenezer ^a,d   Gangaputra, Sapna ^d,e   Rosenbaum, James T ^f   Suhler, Eric B ^f,g   Thorne, Jennifer E ^e   Foster, C Stephen ^h,i   Jabs, Douglas A ^e,j   Levy Clarke, Grace A ^k   Nussenblatt, Robert B ^k   Kempen, John H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g PORTLAND VA MEDICAL CENTER   (United States)

^h MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k NATIONAL EYE INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; PREDNISONE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; COHORT ANALYSIS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERITIS; UVEITIS;

EID: 84864449060     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.01.043     Document Type: Conference Paper

References (13)

1. D.C. Gritz, I.G. Wong Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study Ophthalmology 111 2004 491 500
2. E.B. Suhler, M.J. Lloyd, D. Choi Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest Am J Ophthalmol 146 2008 890 896
3. D.A. Jabs, J.T. Rosenbaum, C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 2000 492 513
4. C. Asensio, P. Muzzin, F. Rohner-Jeanrenaud Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance Int J Obes Relat Metab Disord 28 suppl 2004 S45 S52
5. H. Schäcke, W.D. Döcke, K. Asadullah Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 2002 23 43
6. D.L. Trence Management of patients on chronic glucocorticoid therapy: an endocrine perspective Prim Care 30 2003 593 605
7. P. Bressler, R.A. DeFronzo Drugs and diabetes Diabetes Rev 2 1994 53 84
8. T. Iwamoto, Y. Kagawa, Y. Naito Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases Pharmacotherapy 24 2004 508 514
9. S. Panthakalam, D. Bhatnagar, R. Klimiuk The prevalence and management of hyperglycemia in patients with rheumatoid arthritis on corticosteroid therapy Scott Med J 49 2004 139 141
10. T. Uzu, T. Harada, M. Sakaguchi Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases Nephron Clin Pract 105 2007 c54 c57
11. J.H. Gurwitz, R.L. Bohn, R.J. Glynn Glucocorticoids and the risk for initiation of hypoglycemic therapy Arch Intern Med 154 1994 97 101
12. J.H. Kempen, E. Daniel, S. Gangaputra Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) cohort study Ophthalmic Epidemiol 15 2008 47 55
13. J.H. Kempen, E. Daniel, J.P. Dunn et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study [report online] BMJ 339 2009 b2480 http://www.bmj.com/highwire/filestream/380646/field-highwire-article-pdf/0.pdf Accessed December 30, 2011